A Single and Multiple Ascending Dose Study of LAD603 in Healthy Subjects
Clinical trial NCT06200597 · COMPLETED
Trial details
- NCT number
- NCT06200597
- Sponsor
- Almirall, S.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-05
- Primary completion
- 2025-05-11
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.